Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$12.07 - $19.34 $169,595 - $271,746
-14,051 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$12.5 - $22.04 $81,825 - $144,273
-6,546 Reduced 31.78%
14,051 $218,000
Q4 2019

Feb 13, 2020

BUY
$11.42 - $22.19 $235,217 - $457,047
20,597 New
20,597 $426,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Amia Capital LLP Portfolio

Follow Amia Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Amia Capital LLP with notifications on news.